-
P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease
04 Jun 2025 22:32 GMT
COI Statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the the Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Switzerland and …
-
Memantine HCl Market Analysis 2025 – Insights For Long-Term Investment & Planning
01 Jul 2025 12:32 GMT
… nanotechnology-based delivery, combination drug technologies, AI-powered drug design tools, promotion … increased. The demand for effective drugs like memantine HCl rises in … .p.A., Orchid Pharma Limited, Forest Laboratories LLC, Olon S.p.A …
-
The Verdict Is In: SuperValu Wins at Trial Despite Knowingly Submitting False Claims
26 Jun 2025 23:59 GMT
… )] to change its regulations because [Forest Laboratories] knew that” CMS’ interpretation of … court noted that it viewed Forest Laboratories’ “request for clarification” as “ … account when deciding between competing drugs. Id.
[2] Compare United States …
-
Incyte waves goodbye to longtime CEO Hervé Hoppenot as new appointment raises M&A hopes
26 Jun 2025 22:28 GMT
… up into a competitive commercial drugmaker, the company’s longtime CEO … inhibitor Zynyz, among others. The drugs helped Incyte pull $4.2 … , having started his career at Forest Laboratories, which was bought by Actavis …
-
Incyte Appoints Bill Meury Chief Executive Officer; Hervé Hoppenot to Retire
26 Jun 2025 11:44 GMT
… 20 U.S. Food and Drug Administration (FDA) approvals and new … Vice President Commercial Operations, at Forest Laboratories prior to its acquisition by …
-
Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med
07 Jul 2024 22:44 GMT
… makes Sanofi and Regeneron Pharmaceuticals drug Dupixent the first biologic … his career, Rowe worked at Forest Laboratories, which developed roflumilast, approved by … require hospitalization. Results showed the drug, administered as a subcutaneous injection …
-
Second Circuit dismisses suit against drugmaker that paid competitors to delay generic release
13 May 2024 21:45 GMT
… previous federal court wins for Forest Laboratories.
CVS Pharmacy, Rite Aid and … the market release of the drug.
Forest Laboratories' competitors, including Hetero, Torrent, … for a billion-dollar blockbuster drug was nefarious,” the panel said.
“ …
-
Global Angina Pectoris Treatment Market Report 2022 to 2030 - Featuring Forest Laboratories, Gilead Sciences, GlaxoSmithKline, Novartis and Pfizer Among Others - ResearchAndMarkets.com
31 Jan 2023 14:56 GMT
… pipeline analysis of upcoming potential drugs.
Companies Profiled
Abbott Laboratories Inc … F. Hoffmann-La Roche Ltd.
Forest Laboratories Inc.
Gilead Sciences, Inc.
GlaxoSmithKline … pectoris treatment market comprises potential drugs which are specific and fast …
-
Global Substance Abuse Treatment Market Report to 2030 - Featuring Alkermes, Allergan, Forest Laboratories and GlaxoSmithKline Among Others
30 Jan 2023 10:25 GMT
… market segments based on drug class and different geographical … use of habit forming drugs or substances; leading to … rise in the number of drug addicted population, increased government … 4. Strategic Initiatives
10.3. Forest Laboratories, Inc.
10.3.1. …
-
Dementia Drugs Market to See Booming Growth 2024-2031 | Novartis AG, Sanofi S.A, Eisai, Inc, Janssen Pharmaceuticals,Inc
01 Apr 2024 09:40 GMT
… Drugs Market:
◘ Eisai Inc.
◘ Janssen Pharmaceuticals Inc.
◘ Biogen Pharmaceuticals
◘ Forest Laboratories … :
Global Dementia Drugs Market, By Drug Class:
MAO Inhibitors … Validation and Credibility: Dementia Drugs Market research reports offer …